Transactions
License to
2019
License to
2018
License to
2018
Sale of Royalties to
2018
License To
December 2017
Sale to
2017
Fairness Opinion
2017
Global license
Gaboxadol from
March 2015
$50,000,000 Initial Public Offering / Co-Manager
June 2014
Advisor
February 2014
Global License to
January 2013
$5 Million PIPE
Co-Placement Agent
April 2013
Global Licensing of
IgA Protease
October 2012
Global Licensing of
HuGAL-F2
September 2012
Global Licensing of
HuGAL-FR21
December 2011
Advisor
2010-2011
Advisor
2009-2011
Global license to
May 2010
Advisor
2010
Advisor
2010
$35 Million PIPE
Lead Placement Agent
October 2009
Advisor
2009
Advisor
2009
Advisor
2008-2009
Sale to
May 2008
